Consequently, our discovery of Sema3C as a novel biomarker highlights its key role in mediating bidirectional communication between CSCs and the tumor stroma, driving a vicious cycle that accelerates HCC progression (Fig. 8i). The gene discussed is SEMA3C; the disease is hepatocellular carcinoma.